Arthritis Self-Management Education Program

Not Applicable

Completed

• Conditions: Arthritis
• Interventions: Behavioral: Arthritis Quick Start; Other: Delayed treatment intervention

• Registration Number: NCT00467064
• Lead Sponsor: University of North Carolina, Chapel Hill

Brief Summary

We will develop brief versions of the classic 6-week Arthritis Self-Management Program and evaluate their effectiveness.

Detailed Description

Many national statements have been made recently about the importance of evidence-based arthritis self-management to improvements in the public's health. The prevalence of arthritis is increasing as the US population ages; the prevalence of arthritis-related disability is higher among Blacks than Whites. Effective arthritis self-management education programs with varying formats have been developed and found effective. Despite this, many Arthritis Foundation chapters and arthritis units of state health departments have found dissemination difficult, and cite the time demands (6 weekly sessions, 2 hours/session) of the classic arthritis self-management education program (ASMP) as a major barrier. Researchers at the University of North Carolina at Chapel Hill and Stanford University will develop and evaluate two "low dose" arthritis self-management programs. The study will be conducted in three phases. Phase One (Development): Researchers will conduct needs assessments with arthritis self-management program disseminators, rheumatologists and other arthritis health professionals, and potential program users to determine preferred content, length, and schedule. Using findings from these assessments, researchers will develop two "low dose" versions of the ASMP. Phase Two (Implementation and Evaluation): Researchers will evaluate the "response" (effectiveness) of both "low dose" interventions in a randomized controlled trial (4 months) and a longitudinal study (one year). We will measure four outcomes: (1) Self-Management Behaviors, (2) Arthritis Self-Efficacy, (3) Health-related Quality of Life (Self-reported Health, Pain, Disability, Fatigue, Activity Limitation, and Health Distress); and (4) Health Care Utilization. A sample of 700 adults with diagnosed arthritis or chronic joint pain, including 200 African Americans, will participate in the study. All data will be gathered via self-administered mailed questionnaires, with telephone follow-up as needed. We will use analysis of co-variance and structural equation modeling to evaluate effectiveness. Researchers will also compare the effectiveness of each new "low dose" program with the effectiveness of existing arthritis self-management education program options. Phase Three (Dissemination): We will consult with arthritis units of state health departments and state chapters of the Arthritis Foundation on program adoption and distribution.

Study Timeline

• Study Start: 2006-10
• Study First Submitted: 2007-04-25
• Study First Submitted QC: 2007-04-26
• Study First Posted: 2007-04-27
• Primary Completion: 2007-12
• Study Completion: 2008-12
• Status Verified: 2010-01
• Last Update Submitted: 2010-01-27
• Last Update Posted: 2010-01-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 690

Inclusion Criteria

• Adults, 18 years or older
• Arthritis diagnosis
• No prior participation in arthritis self-management

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Arthritis self-management workshop	Arthritis Quick Start	Comparison of two-week, lay led, scripted self-management workshop emphasizing action planning, problem-solving, and content specific to arthritis.
Arthritis self-management workshop	Delayed treatment intervention	Comparison of two-week, lay led, scripted self-management workshop emphasizing action planning, problem-solving, and content specific to arthritis.
Delayed treatment control	Delayed treatment intervention	After 4 month delay, participants in Control Group receive Experimental intervention.

Primary Outcome Measures

Name	Time	Method
Self-Efficacy	10-1-05-9-30-09

Secondary Outcome Measures

Name	Time	Method
Self-reported health	10-1-05-9-30-09

Trial Locations

Locations (2)

Stanford University Patient Education Research Center; 🇺🇸 Palo Alto, California, United States

University of North Carolina Center for Health Promotion & Disease Prevention; 🇺🇸 Chapel Hill, North Carolina, United States